Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Heart team discussion in managing patients with coronary artery disease: outcome and reproducibility.

Long J, Luckraz H, Thekkudan J, Maher A, Norell M.

Interact Cardiovasc Thorac Surg. 2012 May;14(5):594-8. doi: 10.1093/icvts/ivr157. Epub 2012 Jan 31.

2.

Description of a Heart Team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI.

Bonzel T, Schächinger V, Dörge H.

Clin Res Cardiol. 2016 May;105(5):388-400. doi: 10.1007/s00392-015-0932-2. Epub 2015 Oct 27.

PMID:
26508415
3.

Implementation and consistency of Heart Team decision-making in complex coronary revascularisation.

Pavlidis AN, Perera D, Karamasis GV, Bapat V, Young C, Clapp BR, Blauth C, Roxburgh J, Thomas MR, Redwood SR.

Int J Cardiol. 2016 Mar 1;206:37-41. doi: 10.1016/j.ijcard.2016.01.041. Epub 2016 Jan 6.

PMID:
26774827
4.

Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial.

Campos CM, Stanetic BM, Farooq V, Walsh S, Ishibashi Y, Onuma Y, Garcia-Garcia HM, Escaned J, Banning A, Serruys PW; SYNTAX II Study Group.

Catheter Cardiovasc Interv. 2015 Nov 15;86(6):E229-38. doi: 10.1002/ccd.25907. Epub 2015 May 6.

PMID:
25946686
5.
6.

Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.

Rezende PC, Hueb W, Garzillo CL, Lima EG, Hueb AC, Ramires JA, Kalil Filho R.

J Thorac Cardiovasc Surg. 2013 Nov;146(5):1105-12. doi: 10.1016/j.jtcvs.2012.08.015. Epub 2012 Aug 31.

7.

The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease.

Head SJ, Kaul S, Mack MJ, Serruys PW, Taggart DP, Holmes DR Jr, Leon MB, Marco J, Bogers AJ, Kappetein AP.

Eur Heart J. 2013 Aug;34(32):2510-8. doi: 10.1093/eurheartj/eht059. Epub 2013 Feb 20. Review.

PMID:
23425523
8.

Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.

Head SJ, Holmes DR Jr, Mack MJ, Serruys PW, Mohr FW, Morice MC, Colombo A, Kappetein AP; SYNTAX Investigators.

JACC Cardiovasc Interv. 2012 Jun;5(6):618-25. doi: 10.1016/j.jcin.2012.02.013.

9.

The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.

Kapur A, Bartolini D, Finlay MC, Qureshi AC, Flather M, Strange JW, Hall RJ.

J Cardiovasc Med (Hagerstown). 2010 Jan;11(1):26-33. doi: 10.2459/JCM.0b013e328330ea32.

PMID:
19797974
10.

Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine.

Gao ZY, Xu H, Shi DZ, Wen C, Liu BY.

J Ethnopharmacol. 2012 Jun 1;141(2):578-83. doi: 10.1016/j.jep.2011.08.071. Epub 2011 Sep 8.

PMID:
21924336
11.

Optimal treatment for coronary artery disease in patients with diabetes: percutaneous coronary intervention, coronary artery bypass graft, and medications.

Ito H.

Gen Thorac Cardiovasc Surg. 2011 Jan;59(1):6-13. doi: 10.1007/s11748-010-0648-1. Epub 2011 Jan 12. Review.

PMID:
21225393
12.

Structure and functioning of a multidisciplinary 'Heart Team' for patients with coronary artery disease: rationale and recommendations from a joint BCS/BCIS/SCTS working group.

Luckraz H, Norell M, Buch M, James R, Cooper G.

Eur J Cardiothorac Surg. 2015 Oct;48(4):524-9. doi: 10.1093/ejcts/ezv083. Epub 2015 Mar 11. Review.

PMID:
25762394
13.

Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW; SYNTAX Investigators.

N Engl J Med. 2009 Mar 5;360(10):961-72. doi: 10.1056/NEJMoa0804626. Epub 2009 Feb 18. Erratum in: N Engl J Med. 2013 Feb 7;368(6):584.

14.

Coronary revascularization for patients with unprotected left main coronary artery disease: evidence, guidelines, and judgment! Making clinical decisions in 2009.

Moussa ID, Wong SC, Feldman T.

Catheter Cardiovasc Interv. 2009 Sep 1;74(3):448-58. doi: 10.1002/ccd.22088. Review.

PMID:
19434750
15.

Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.

Lenzen MJ, Boersma E, Bertrand ME, Maier W, Moris C, Piscione F, Sechtem U, Stahle E, Widimsky P, de Jaegere P, Scholte op Reimer WJ, Mercado N, Wijns W; European Society of Cardiology.

Eur Heart J. 2005 Jun;26(12):1169-79. Epub 2005 Mar 31.

PMID:
15802360
16.

Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data.

Head SJ, Mack MJ, Holmes DR Jr, Mohr FW, Morice MC, Serruys PW, Kappetein AP.

Eur J Cardiothorac Surg. 2012 Mar;41(3):535-41. doi: 10.1093/ejcts/ezr105. Epub 2011 Dec 21.

PMID:
22219412
17.

Bypass Grafting Versus Percutaneous Intervention-Which Is Better in Multivessel Coronary Disease: Lessons From SYNTAX and Beyond.

Farooq V, Serruys PW.

Prog Cardiovasc Dis. 2015 Nov-Dec;58(3):316-34. doi: 10.1016/j.pcad.2015.10.002. Epub 2015 Oct 31. Review.

PMID:
26529569
18.

Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II.

Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, Kappetein AP, Colombo A, Holmes DR Jr, Mack M, Feldman T, Morice MC, Ståhle E, Onuma Y, Morel MA, Garcia-Garcia HM, van Es GA, Dawkins KD, Mohr FW, Serruys PW.

Lancet. 2013 Feb 23;381(9867):639-50. doi: 10.1016/S0140-6736(13)60108-7.

PMID:
23439103
19.

Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.

Capodanno D, Caggegi A, Miano M, Cincotta G, Dipasqua F, Giacchi G, Capranzano P, Ussia G, Di Salvo ME, La Manna A, Tamburino C.

JACC Cardiovasc Interv. 2011 Mar;4(3):287-97. doi: 10.1016/j.jcin.2010.10.013.

20.

Surgical Revascularization versus Percutaneous Coronary Intervention and Optimal Medical Therapy in Diabetic Patients with Multi-Vessel Coronary Artery Disease.

Giustino G, Dangas GD.

Prog Cardiovasc Dis. 2015 Nov-Dec;58(3):306-15. doi: 10.1016/j.pcad.2015.08.005. Epub 2015 Aug 5. Review.

PMID:
26255239

Supplemental Content

Support Center